Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2003
09/12/2003CA2477505A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477125A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2477003A1 Compounds and methods of treating cell proliferative diseases
09/12/2003CA2476580A1 Thiazole and oxazole derivatives that modulate ppar activity
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003US20030171773 Methods for aneurysm repair
09/11/2003US20030171584 6-Substituted pyrido-pyrimidines
09/11/2003US20030171579 N-benzyl-N'-phenylurea derivatives; inhibitors of the coagulation factors Xa and VIIa
09/11/2003US20030171564 Novel argS
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171537 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
09/11/2003US20030171438 Method for treatment of external secretion disorders
09/11/2003US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171415 Strokes; cardiovascular disorders; mixture of melmisartan and ramipril
09/11/2003US20030171414 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171400 Rheumatic diseases; osteoporosis; multiple sclerosis; autoimmune disease; joint replacements
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/11/2003US20030171381 Therapy for Parkinson's disease; antidepressants; antiepileptic agents
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171378 Indolinone derivatives
09/11/2003US20030171361 Treatment of impotence, sexual dysfunction in female, stable, unstable and variant angina, hypertension, pulmonary hypertension, congestive heart failure, atherosclerosis
09/11/2003US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases
09/11/2003US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/11/2003US20030171354 Indole derivatives
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171324 Reagents which bind to human DESC1-like serine protease gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cancer, chronic obstructive pulmonary disease (COPD),
09/11/2003US20030171309 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
09/11/2003US20030171304 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
09/11/2003US20030171294 Unit angiogenic agent, typically from 5 ng to 67,500 ng. Preferably, the angiogenic agent is FGF, more preferably it is basic FGF, Inducing angiogenesis or myocardial perfusion or vascular density into a heart
09/11/2003US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
09/11/2003US20030171287 Medicinal compositions for angiogenic therapy
09/11/2003US20030171271 Therapeutic application in the treatment of conditions including cancer, macular degeneration and retinopathies. Also included are methods of treating a patient having a pathological condition characterized by an increase in
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170854 Recombinant human creatine kinase heterodimer with solution-stability
09/11/2003US20030170839 Type 2 cytokine receptor and nucleic acids encoding same
09/11/2003US20030170811 Culturing a microorganism transformed with an expression vector comprising a gene encoding an amino acid sequence of a peptide-fused atriopeptin; use as antihypertensive diuretic agent
09/11/2003US20030170808 Polypeptide encoded by polynucleotide of given sequence; use in diagnosis and treatment of various diseases
09/11/2003US20030170708 Screening for mutants; primer amplification
09/11/2003US20030170685 Canine hepatocyte growth factor
09/11/2003US20030170643 Regulation of apoB treatment and drug screening for cardiovascular and metabolic disorders or syndromes
09/11/2003US20030170331 Plant extract of the olea europaea as no-synthase inhibitor and uses
09/11/2003US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter
09/11/2003US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
09/11/2003US20030170289 Injectable depot compositions and uses thereof
09/11/2003US20030170287 Rapamycin or a rapamycin derivative having mTOR inhibiting properties
09/11/2003US20030170253 Useful in stimulating angiogenesis as well as in diagnostic applications.
09/11/2003US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood
09/10/2003EP1343013A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents.
09/10/2003EP1342721A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
09/10/2003EP1342717A1 Benzimidazole derivatives
09/10/2003EP1342475A1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341918A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341821A1 Thermoplastic and water soluble cellulose ether esters
09/10/2003EP1341819A2 Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
09/10/2003EP1341814A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/10/2003EP1341795A2 Novel labeled resiniferatoxin derivatives
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341768A1 Therapeutic benzimidazole compounds
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341765A1 Therapeutic compounds
09/10/2003EP1341764A1 Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341755A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341543A2 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
09/10/2003EP1341541A1 Combination therapy for lowering and controlling intraocular pressure
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1341476A2 Intrasvascular drug delivery device and use therefor
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP1253937B1 Use of thrombin derived peptides for the treatment of cardiovascular disorders
09/10/2003EP1194401B1 Diacylhydrazine derivatives
09/10/2003EP1165136B1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease
09/10/2003EP1157987B1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
09/10/2003EP1147115B1 Tricyclic benzodiazepines as vasopressin receptor antagonists
09/10/2003EP1137644B1 Benzofuran derivatives, their preparation and use
09/10/2003EP1135139B1 Micronized eplerenone compositions
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP0996454B1 Use of polyallylamine polymers for the manufacture of a medicament for treating hypercholesterolemia
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003CN1441808A Chemokine receptor modulators, production and use
1 ... 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 ... 1595